BIMI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BIMI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Gross Margin % is calculated as gross profit divided by its revenue. BIMI International Medical's Gross Profit for the three months ended in Sep. 2023 was $0.12 Mil. BIMI International Medical's Revenue for the three months ended in Sep. 2023 was $2.52 Mil. Therefore, BIMI International Medical's Gross Margin % for the quarter that ended in Sep. 2023 was 4.56%.
The historical rank and industry rank for BIMI International Medical's Gross Margin % or its related term are showing as below:
During the past 13 years, the highest Gross Margin % of BIMI International Medical was 40.30%. The lowest was 2.47%. And the median was 15.68%.
BIMI International Medical had a gross margin of 4.56% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for BIMI International Medical was 0.00% per year.
The historical data trend for BIMI International Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIMI International Medical Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Gross Margin % | Get a 7-Day Free Trial | - | - | 19.02 | 11.38 | 16.48 |
BIMI International Medical Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Gross Margin % | Get a 7-Day Free Trial | 14.25 | 29.69 | 52.85 | 51.89 | 4.56 |
For the Pharmaceutical Retailers subindustry, BIMI International Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where BIMI International Medical's Gross Margin % falls into.
Gross Margin is the percentage of Gross Profit out of sales or Revenue.
BIMI International Medical's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as
Gross Margin % (A: Dec. 2022 ) | = | Gross Profit (A: Dec. 2022 ) | / | Revenue (A: Dec. 2022 ) |
= | 2 | / | 11.83 | |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | (11.83 - 9.88) | / | 11.83 | |
= | 16.48 % |
BIMI International Medical's Gross Margin for the quarter that ended in Sep. 2023 is calculated as
Gross Margin % (Q: Sep. 2023 ) | = | Gross Profit (Q: Sep. 2023 ) | / | Revenue (Q: Sep. 2023 ) |
= | 0.1 | / | 2.523 | |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | (2.523 - 2.408) | / | 2.523 | |
= | 4.56 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
BIMI International Medical (NAS:BIMI) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
BIMI International Medical had a gross margin of 4.56% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Thank you for viewing the detailed overview of BIMI International Medical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Ang Sammi Ean Seok | director | 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709 |
Fnu Oudom | director | 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618 |
Xiaoping Wang | director | ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037 |
Baiqun Zhong | officer: CFO | 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039 |
Zhang Tingting | director, officer: Chief Financial Officer | 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001 |
Song Tiewei | director | 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001 |
Yongquan Bi | 10 percent owner | ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001 |
Wang Lihua | director, 10 percent owner, officer: Chief Financial Officer | NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003 |
Li Gang | director, 10 percent owner, officer: President and CEO | 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000 |
Jiuding Yan | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021 |
Lesley Jin | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021 |
Maclean John Coleman | director | 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501 |
Zhongmin Wang | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021 |
Jianxin Wang | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021 |
Mia Kuang Ching | director | C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-30-2022
By PurpleRose PurpleRose • 07-11-2022
By GuruFocusNews GuruFocusNews • 06-11-2022
By GuruFocusNews GuruFocusNews • 06-07-2022
By GuruFocusNews GuruFocusNews • 05-18-2022
By GuruFocusNews GuruFocusNews • 07-08-2022
By GuruFocusNews GuruFocusNews • 06-01-2022
By GuruFocusNews GuruFocusNews • 06-17-2022
By Marketwired • 08-24-2023
By GuruFocusNews GuruFocusNews • 07-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.